Company page

Hemab Therapeutics Holdings, Inc.

Hemab Therapeutics Holdings, Inc. is a public company traded under the ticker COAG in the American market. The company has a market capitalization of approximately $2.3 billion. Hemab focuses on developing innovative therapies for patients with rare diseases.